Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

soichiro yoshida

Institute of Science Tokyo

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Medical Imaging Medical Imaging professors in Japan

Articles (10)

Year:

2025

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Yuma Waseda

Tokyo Institute of Technology

JAPAN

View details

Motohiro Fujiwara

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Hajime Tanaka

Assistant Professor

Tokyo Medical and Dental University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

soichiro yoshida

Research Interests

Make your next move.

Explore related searches

Articles (10)

Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer

Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma

Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response

Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer?

Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity

Combination of cisplatin and irradiation induces immunogenic cell death and potentiates postirradiation anti–PD-1 treatment efficacy in urothelial carcinoma

Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer

Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab

Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy

Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy

Collaborators (3)

Yuma Waseda

Motohiro Fujiwara

Hajime Tanaka

Make your next move.